enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Isavuconazonium - Wikipedia

   en.wikipedia.org/wiki/Isavuconazonium

   Isavuconazonium, sold under the brand name Cresemba, is a systemic antifungal medication of the triazole class which is used to treat invasive aspergillosis and mucormycosis. [9] [7] [8] [12] It is used as the sulfate. [9] It is taken by mouth or given via injection into a vein. [9]

3. As fungal infections grow resistant to medication, desperate ...

   www.aol.com/news/fungal-infections-grow...

   After living with a severe fungal allergy for about 40 years, Jill Fairweather is running out of treatment options. Now 65, Fairweather was diagnosed with aspergillosis, a disease caused by the ...

4. Allergic bronchopulmonary aspergillosis - Wikipedia

   en.wikipedia.org/wiki/Allergic_bronchopulmonary...

   The chest radiograph of an allergic bronchopulmonary aspergillosis patient shown with left-sided perihilar opacity (blue arrow) along with non-homogeneous infiltrates (transient pulmonary infiltrates indicated by red arrows) in all zones of both lung fields. The conidiophore of the fungal organism Aspergillus fumigatus. Specialty

5. Aspergillosis - Wikipedia

   en.wikipedia.org/wiki/Aspergillosis

   Galactomannan is a component of the fungal wall. [13] False-positive Aspergillus galactomannan tests have been found in patients on intravenous treatment with some antibiotics or fluids containing gluconate or citric acid such as some transfusion platelets, parenteral nutrition, or PlasmaLyte. [25] [26]

6. Itraconazole - Wikipedia

   en.wikipedia.org/wiki/Itraconazole

   Itraconazole, sometimes abbreviated ITZ, is an antifungal medication used to treat a number of fungal infections. [7] This includes aspergillosis, blastomycosis, coccidioidomycosis, histoplasmosis, and paracoccidioidomycosis. [7] It may be given by mouth or intravenously. [7]

7. Antifungal drug developer F2G raises $100 million to fight ...

   www.aol.com/news/antifungal-drug-developer-f2g...

   In 2020, 20 large drugmakers founded the AMR Action Fund to boost the pipeline of antifungal and antibiotic drugs, with a target of enabling as much as four novel antibiotics to hit the market by ...